All-Cause and Cause-Specific Mortality Risks Associated With Alopecia Areata

Abstract

IMPORTANCE Alopecia areata is associated with diverse systemic and psychiatric diseases. However, whether all-cause and cause-specific mortality in patients with alopecia areata differs from that of the general population remains unclear. OBJECTIVE To investigate all-cause and cause-specific mortality risk in patients with alopecia areata. DESIGN, SETTING, AND PARTICIPANTS Using the National Health Insurance Service database and National Death Registry of Korea, a retrospective cohort study of participants identified in 2006, with investigation of mortality until 2016, was carried out. Patients with alopecia areata with at least 3 documented visits to a dermatologist with an International Statistical Classification of Diseases (tenth revision) code of L63 during 2002 to 2006 were included. For comparison, 1:10 age-and sex-matched controls without documented visits with a code of L63 until 2016 were included. EXPOSURES Patients with alopecia areata and controls without alopecia areata. MAIN OUTCOMES AND MEASURES The study population was followed from January 1, 2007, for a period of 10 years to estimate all-and cause-specific mortality. RESULTS The study comprised 73 107 patients with alopecia areata and 731 070 age-and sex-matched controls. Of these, 6023 were patients with alopecia totalis/universalis. No differences in all-cause mortality risk between the cohorts were found (HR, 0.97; 95% CI, 0.87-1.09). However, mortality associated with intentional self-harm/psychiatric diseases was greater in patients than in participants in the control group (HR, 1.21; 95% CI, 1.04-1.41). Adult patients aged 35 years or younger (HR, 1.68; 95% CI, 1.32-2.12) and those with alopecia totalis/universalis (HR, 1.85; 95% CI, 1.25-2.75) were particularly affected. Mortality associated with lung cancer was greater in patients with alopecia totalis/universalis (HR, 2.16; 95% CI, 1.41-3.33). However, mortality associated with diabetes mellitus was significantly lower in patients with alopecia areata (HR, 0.53; 95% CI, 0.36-0.79). CONCLUSIONS AND RELEVANCE Patients with alopecia areata have a higher risk of mortality associated with self-harm, psychiatric diseases, and smoking-associated malignant diseases including lung cancer. For better outcomes, clinicians should appropriately treat patients to ensure emotional and psychological well-being.

Validation of case identification for alopecia areata using international classification of diseases coding

“…In a Korean study, 209 of the 220 patients with an ICD 10 code of L63 who had their chart reviewed were confirmed to have AA, resulting in a PPV of 95.0%. [ 5 ] The criteria used to validate the charts was not described. Overall, our PPVs lie within the range of those published by previous studies.…”

Alopecia areata is not a risk factor for heart diseases: A 10-year retrospective cohort study

“…A study by Huang et al found that AA was not related to an increased risk of acute myocardial infarction without statistical significance [ 8 ]. In addition, Lee et al showed the risk of cardiovascular mortality is not associated with presence of AA [ 26 ]. However, Shin et al claimed significantly increased risk of acute myocardial infarction in patients with AA only in the later stage of the observation [ 27 ].…”

Trends of age‐related non‐communicable diseases in people living with HIV and comparison with uninfected controls: A nationwide population‐based study in South Korea

“…If clinicians enter the wrong diagnosis, the claim is refused according to the Health Insurance Review and Assessment Service's assessment evaluation [13]. Thus, it is assumed that the entered diagnostic code is reliable and extensive research has been conducted on this subject in Korea [14,15].…”